Significant response of low-dose apatinib monotherapy in brain metastases of triple-negative breast cancer: A case report.

AbstractRationale:The potential efficacy of apatinib in patients with advanced triple-negative breast cancer (TNBC) has been observed in a previous phase II clinical study. However, there is no study to evaluate its efficacy and safety in TNBC patients with brain metastasis (BM). Here we report one